Non-small Cell Lung Carcinoma
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-09Clinical Trial Results: A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of pegylated IL-10 (pegilodecakin) in adults with advanced solid tumors; results from a first-in-human trial assessing safety …
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Results: A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495/KEYNOTE-495) [Phase 2]
Phase 2 trial assessing biomarker-directed pembrolizumab-based combination therapy in advanced non-small cell lung cancer has completed with…
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Pembrolizumab for Metastatic NSCLC Patients Expressing PD-L1 Who Have Their Own PDX [Phase 4]
Phase 4 clinical trial evaluating Pembrolizumab in metastatic non-small cell lung cancer patients expressing PD-L1 who have their own patien…
-
CLINICAL_TRIALS trial_result · 2024-04-11Clinical Trial Update: Merestinib In Non-Small Cell Lung Cancer And Solid Tumors [Phase 2]
Phase 2 trial update for merestinib in non-small cell lung cancer and solid tumors; study terminated with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20) [Phase 3]
Phase 3 trial update for epoetin alfa in advanced non-small cell lung cancer has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung Cancer [Phase 2]
Phase 2 trial evaluating biomarkers for nivolumab and ipilimumab and their combination in lung cancer.
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: SHR-1701 Combined With Fluzoparib in Lung Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating SHR-1701 in combination with Fluzoparib for non-small cell lung cancer (lung squamous cell carcinoma).
-
CLINICAL_TRIALS trial_result · 2023-12-26Clinical Trial Update: Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL) [Phase 3]
A Phase 3 trial evaluating durvalumab alone or with chemotherapy for advanced non-small cell lung cancer (NSCLC) is active/not recruiting wi…
-
CLINICAL_TRIALS trial_result · 2023-07-24Clinical Trial Update: Genetic Predictors of Benefit to Pembrolizumab [Phase 2]
Phase 2 trial investigating genetic predictors of benefit to pembrolizumab in non-small cell lung carcinoma; the study was terminated with r…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: Atezolizumab Immunotherapy in Patients With Advanced NSCLC [Phase 2]
Phase 2 clinical trial update of atezolizumab immunotherapy in patients with advanced non-small cell lung carcinoma; results posted after co…
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Study Comparing Bevacizumab + Erlotinib vs Erlotinib Alone as First Line Treatment of Patients With EGFR Mutated Advanced Non Squamous Non Small Cell Lung Cancer [Phase 3]
A phase 3 clinical trial comparing bevacizumab plus erlotinib versus erlotinib alone as first-line treatment for EGFR-mutated advanced non-s…
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: A Study Comparing Immunotherapy With Chemotherapy in the Treatment of Elderly Patients With Advanced NSCLC (MILES-5) [Phase 2]
A Phase 2 clinical trial comparing immunotherapy with chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC).
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor (TKI) Therapy [Phase 3]
Phase 3 trial comparing nivolumab plus chemotherapy or nivolumab plus ipilimumab versus chemotherapy in EGFR-mutant NSCLC after failure of 1…
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: A Study of Atezolizumab Compared With Docetaxel in Non-Small Cell Lung Cancer (NSCLC) After Failure With Platinum-Containing Chemotherapy [Phase 3]
Phase 3 trial comparing atezolizumab to docetaxel in non-small cell lung cancer after platinum-based chemotherapy failure has completed.
-
CLINICAL_TRIALS trial_result · 2022-06-28Clinical Trial Update: Study to Evaluate Erlotinib With or Without SNDX-275 (Entinostat) in the Treatment of Patients With Advanced NSCLC [Phase 1, Phase 2]
A completed early-phase study evaluating erlotinib with or without entinostat (SNDX-275) in advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Efficacy and Safety of DEB-BACE With Sequential Arotinib and Tirelizumab in the Treatment of Advanced NSCLC [Phase 2]
Phase 2 clinical trial evaluating DEB-BACE with sequential arotinib and tirelizumab for advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Evaluate the Impact of Afatinib on Quality of Life and Symptom Burden of Greek Subjects With Advanced NSCLC in Routine Patient Care Settings
A completed clinical trial evaluating the impact of afatinib on quality of life and symptom burden in Greek patients with advanced non-small…
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Testing Afatinib in Combination With Pembrolizumab in Patients With Squamous Cell Carcinoma of the Lung [Phase 2]
Phase 2 trial updating afatinib in combination with pembrolizumab for non-small cell lung carcinoma (squamous cell) has been completed with …
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: Nintedanib and Weekly Docetaxel in Lung Adenocarcinoma [Phase 1]
Phase 1 trial update evaluating nintedanib with weekly docetaxel in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-12-24Clinical Trial Update: Afatinib Osimertinib Sequencing NIS
A completed clinical trial evaluating sequencing of afatinib and osimertinib in non-small cell lung carcinoma; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer [Phase 2]
Phase 2 trial of PF-00299804 in patients with advanced refractory non-small cell lung carcinoma completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Pazopanib in Molecularly Selected Patients With Advanced NSCLC [Phase 2]
Phase 2 trial update of Pazopanib in molecularly selected patients with advanced non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2020-07-10Clinical Trial Update: A Study of DS-2248 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 trial update for DS-2248 in advanced solid tumors; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-06-24Clinical Trial Update: Study of Carotuximab (TRC105) Plus Nivolumab in Patients With Metastatic NSCLC [Phase 1]
Phase 1 study of Carotuximab (TRC105) in combination with Nivolumab in metastatic non-small cell lung carcinoma has completed with results p…
-
CLINICAL_TRIALS trial_result · 2020-05-26Clinical Trial Update: Trial of Image-Guided Adaptive Conformal Photon vs Proton Therapy, With Concurrent Chemotherapy, for Locally Advanced Non-Small Cell Lung Carcinoma: Treatment Related Pneumonitis and Locoregional Recurrence [Phase 2]
Phase 2 trial comparing image-guided adaptive conformal photon therapy versus proton therapy with concurrent chemotherapy for locally advanc…